会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD OF SCREENING FOR ANTIDIABETIC AGENTS
    • 抗生素代谢筛选方法
    • WO2004005550A3
    • 2004-04-15
    • PCT/JP0308523
    • 2003-07-04
    • FUJISAWA PHARMACEUTICAL COFUJIMURA TAKAOSAKUMA HIROYUKIKIMURA CHIAKIOE TOMOYAARAMORI ICHIRO
    • FUJIMURA TAKAOSAKUMA HIROYUKIKIMURA CHIAKIOE TOMOYAARAMORI ICHIRO
    • A61P3/08G01N33/50G01N33/68G01N33/92
    • G01N33/5044G01N33/5008G01N33/5023G01N33/6872G01N33/92G01N2333/70567G01N2800/042
    • A method of screening for an antidiabetic agent that lowers blood glucose level without inducing obesity and/or insulin resistance, is provided. The method comprises measuring the expression level of a nuclear peroxisome proliferator-activated receptor g (PPARg)-induced adipogenic gene in mature adipocytes in the presence of a test compound or a PPARg full agonist and selecting a compound that results in an expression level significantly lower than that measured using the PPARg full agonist. The method may further comprise the same steps except for using differentiating adipocytes to select a compound that results in an expression level comparable to or higher than that measured using the PPARg full agonist. A kit used for the above screening method, a compound obtainable by the screening method, a pharmaceutical composition containing such a compound, and a method lowering the blood glucose level without causing obesity and/or insulin resistance using the compound, are also provided.
    • 提供了筛选降低血糖水平而不诱导肥胖和/或胰岛素抵抗的抗糖尿病药的方法。 该方法包括在受试化合物或PPARg全激动剂的存在下测量成熟脂肪细胞中核过氧化物酶体增殖物激活受体g(PPARg)诱导的脂肪形成基因的表达水平,并选择导致表达水平显着降低的化合物 比使用PPARg全激动剂测量的。 该方法可以进一步包括相同的步骤,除了使用分化脂肪细胞来选择导致与使用PPARg全激动剂测量的表达水平相当或更高的表达水平的化合物。 还提供了用于上述筛选方法的试剂盒,通过筛选方法获得的化合物,含有这种化合物的药物组合物,以及使用该化合物降低血糖水平而不引起肥胖和/或胰岛素抵抗的方法。